Searched over 200M research papers
10 papers analyzed
These studies suggest that shortness of breath can be managed through therapeutic measures like physical activity and relaxation exercises, multimodal approaches, chest therapy, breathing exercises, and potentially oxygen therapy and opioids, though more research is needed for certain conditions.
19 papers analyzed
Shortness of breath, also known as dyspnea, is a common and distressing symptom experienced by patients with various underlying conditions, including advanced cancer, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. This article synthesizes current research on the treatment options available for managing this symptom.
General measures such as reassurance, development of an emergency plan, physical activity, and relaxation exercises are recommended to address shortness of breath in palliative care settings. These interventions help improve the patient's overall well-being and reduce the sensation of breathlessness.
Breathing exercises and chest physiotherapy have shown effectiveness in improving breathing effort, particularly in patients with COVID-19. These therapies help maximize lung expansion and enhance respiratory function, leading to reduced shortness of breath. Additionally, a combination of Pursed Lip Breathing (PLB) and Progressive Muscle Relaxation (PMR) has been found to significantly decrease dyspnea in COPD patients.
Supportive non-pharmacological measures such as the use of a rollator and exposure to a cool draft of air from a handheld fan can also provide relief from shortness of breath. These interventions are supported by evidence and are recommended for patients experiencing dyspnea.
Opioids are considered the medications of choice for managing shortness of breath in palliative care. They have been shown to effectively reduce the sensation of breathlessness with low toxicity. Morphine and dextromethorphan are commonly used opioids for this purpose .
Although benzodiazepines are often used to manage dyspnea, a meta-analysis did not reveal any statistically significant benefit from their use. Therefore, their effectiveness in treating shortness of breath remains uncertain.
For patients with marked sputum formation, expectorants can help alleviate coughing, which in turn can reduce the sensation of breathlessness. Antitussants, which suppress the cough reflex, are also effective in managing cough-related dyspnea.
Preliminary data suggest that acupuncture may relieve dyspnea in cancer patients. However, a pilot study found that the effects of acupuncture on dyspnea were not significantly different from placebo, indicating that further research is needed to establish its efficacy.
Proper diagnosis of the underlying cause of shortness of breath is crucial for effective treatment. Pulmonary function tests are essential for diagnosing obstructive airway disorders and other conditions that cause dyspnea. However, a significant proportion of patients treated with inhalers for presumed obstructive airway disorders may not have undergone these tests, highlighting the need for confirmatory testing before prescribing inhalers.
Managing shortness of breath requires a multifaceted approach that includes both non-pharmacological and pharmacological interventions. Physical activity, breathing exercises, and the use of assistive devices can provide significant relief. Opioids remain the most effective pharmacological treatment, while the role of benzodiazepines and alternative therapies like acupuncture requires further investigation. Accurate diagnosis through pulmonary function tests is essential for tailoring appropriate treatments. By combining these strategies, healthcare providers can improve the quality of life for patients experiencing dyspnea.
Most relevant research papers on this topic